{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:06:23Z","timestamp":1765040783105},"reference-count":32,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Onset of symptoms in severe sporadic neurofibromatosis type 2 (NF2) is typically within childhood; however, there is poor awareness of presenting features in young children, potentially resulting in delayed diagnosis and poorer outcome. We have reviewed presentation of sporadic paediatric NF2 to raise awareness of early features, highlighting those requiring further investigation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Patients diagnosed with NF2 at age \u226416\u2009and seen between 2012 and 2015 were notified via the British Paediatric Neurology Surveillance Unit or identified through the English NF2 service.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Epidemiological data estimate that 1 in 110\u2009611 births are affected with childhood-onset NF2. Notes of 32 patients with sporadic NF2 were reviewed. Of those presenting under the age of 5, 89% (17\/19) had ocular, 74% (14\/19) dermatological and 58% (11\/19) neurological signs; in 84% (16\/19) features were multisystemic. Sixty-six per cent (21\/32) had \u22651\u2009atypical feature, including cerebellar hypoplasia in three cases (9%) and focal cortical dysplasia in five out of seven seizure-related presentations. Five cases presented with a sometimes transient or intermittent cranial nerve mononeuropathy. The mean delay to diagnosis was 3.16 years; in eight cases (25%) this exceeded 6 years. Most significant delay occurred in mononeuropathy, ophthalmological and\/or seizure presentations, with a mean delay of 3, 4.5 and 6 years, respectively. Eighty-four per cent (27\/32) of cases needed intervention in childhood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>All non-vestibular schwannoma NF2 presentations in childhood had significant diagnostic delay. We emphasise the importance of detailed assessment of skin and eyes in unusual presentations and propose an aide to prompt timely referral to specialist services.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2017-313154","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T16:20:24Z","timestamp":1520958024000},"page":"463-469","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population"],"prefix":"10.1136","volume":"103","author":[{"given":"Geetha","family":"Anand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Vasallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Spanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didu Sanduni","family":"Kariyawasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Durie-Gair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Lascelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Everett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances Mary","family":"Gibbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Elston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafydd Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"2020050712442198000_103.5.463.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139"},{"key":"2020050712442198000_103.5.463.2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-16"},{"key":"2020050712442198000_103.5.463.3","doi-asserted-by":"publisher","DOI":"10.1136\/adc.81.6.496"},{"key":"2020050712442198000_103.5.463.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01816.x"},{"key":"2020050712442198000_103.5.463.5","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-104519"},{"key":"2020050712442198000_103.5.463.6","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199307000-00014"},{"issue":"Pt 1","key":"2020050712442198000_103.5.463.7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/eye.1997.3","article-title":"The ocular presentation of neurofibromatosis 2","volume":"11","author":"Ragge","year":"1997","journal-title":"Eye"},{"key":"2020050712442198000_103.5.463.8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480059008"},{"key":"2020050712442198000_103.5.463.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9091(98)80003-X"},{"key":"2020050712442198000_103.5.463.10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.braindev.2013.01.007","article-title":"Characterization of early onset neurofibromatosis type 2","volume":"36","author":"Matsuo","year":"2014","journal-title":"Brain Dev"},{"key":"2020050712442198000_103.5.463.11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.spen.2015.10.008","article-title":"Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms","volume":"22","author":"Ruggieri","year":"2015","journal-title":"Semin Pediatr Neurol"},{"key":"2020050712442198000_103.5.463.12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.0000000000003418","article-title":"Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1 -related schwannomatosis","volume":"88","author":"Smith","year":"2017","journal-title":"Neurology"},{"key":"2020050712442198000_103.5.463.13","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.12.841"},{"key":"2020050712442198000_103.5.463.14","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103290"},{"key":"2020050712442198000_103.5.463.15","first-page":"657","article-title":"Neurofibromatosis type 2 service delivery in England","volume":"54","author":"Lloyd","year":"2017","journal-title":"Neurochirurgie"},{"key":"2020050712442198000_103.5.463.16","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-837581"},{"key":"2020050712442198000_103.5.463.17","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q J Med"},{"key":"2020050712442198000_103.5.463.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.12.042"},{"key":"2020050712442198000_103.5.463.19","doi-asserted-by":"publisher","DOI":"10.1177\/08830738030180101301"},{"key":"2020050712442198000_103.5.463.20","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e31825e73f5"},{"key":"2020050712442198000_103.5.463.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1828-8"},{"key":"2020050712442198000_103.5.463.22","first-page":"281","article-title":"Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation","volume":"3","author":"Morris","year":"2016","journal-title":"Neurooncol Pract"},{"key":"2020050712442198000_103.5.463.23","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000119"},{"key":"2020050712442198000_103.5.463.24","first-page":"216","article-title":"[High blood pressure due to aortic coarctation and renal artery stenosis in a teenager with type 1 neurofibromatosis]","volume":"28","author":"Pardo","year":"2008","journal-title":"Nefrologia"},{"key":"2020050712442198000_103.5.463.25","first-page":"235","article-title":"Neurofibromatosis type 1 complicated by atypical coarctation of the thoracic aorta","volume":"93","author":"Kimura","year":"2017","journal-title":"Case Rep Pediatr"},{"key":"2020050712442198000_103.5.463.26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.34035"},{"key":"2020050712442198000_103.5.463.27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12311-015-0658-8","article-title":"Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1","volume":"14","author":"Toelle","year":"2015","journal-title":"Cerebellum"},{"key":"2020050712442198000_103.5.463.28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2156-7514.112802","article-title":"An uncommon case of neurofibromatosis type 2: a tribute to the intracranial calcifications","volume":"3","author":"Ozg\u00fcr","year":"2013","journal-title":"J Clin Imaging Sci"},{"key":"2020050712442198000_103.5.463.29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10048-013-0354-0","article-title":"Natural history of neurofibromatosis type 2 with onset before the age of 1\u00a0year","volume":"14","author":"Ruggieri","year":"2013","journal-title":"Neurogenetics"},{"key":"2020050712442198000_103.5.463.30","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.34.11.934"},{"key":"2020050712442198000_103.5.463.31","first-page":"178","article-title":"[Clinically isolated Morning glory syndrome]","volume":"25","author":"Schneider","year":"2002","journal-title":"J Fr Ophtalmol"},{"key":"2020050712442198000_103.5.463.32","first-page":"839","article-title":"Morning glory disc anomaly in neurofibromatosis type 2","volume":"117","author":"Brodsky","year":"1999","journal-title":"Arch Ophthalmol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2017-313154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:06:34Z","timestamp":1601071594000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2017-313154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/archdischild-2017-313154"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2017-313154","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]}}}